Cure My Disease

Don't miss your cure!

 Log in / Sign up

Chest wrinkle filler put to the test — will it interfere with breast cancer screening?

NCT ID NCT04717934

Symptom relief Sponsor: Galderma R&D Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study tests a hyaluronic acid filler called GAL1906 to smooth wrinkles on the décolletage (upper chest). It also checks whether the filler affects how mammograms are read, which is important for breast cancer detection. Participants are women over 21 seeking treatment for chest wrinkles. The main study compares the filler to no treatment, and a sub-study looks at mammogram images from treated participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
hyaluronic acid dermal filler gel
What this could lead to
If successful, this could offer a safe, non-surgical option for reducing wrinkles on the chest without affecting breast cancer screening.
What could go wrong
This is a small, early-stage study. Results may not apply to everyone, and there is a risk the filler could interfere with mammogram interpretation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

211 people

The number who actually took part.

Started

Feb 2021

Finished

Jun 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Main study: * Subjects willing to comply with the requirements of the study and providing a signed written informed consent. * Non-pregnant, non-breastfeeding females, over the age of 21. * Subjects seeking treatment for the décolletage. Inclusion Criteria for Sub-study: * Subject was willing to comply with the requirements of the study and provide a signed written informed consent. * Subject had received treatment with GAL1906 in the main protocol. Exclusion Criteria for Main study: * Known/previous allergy or hypersensitivity to any injectable HA gel or to gram positive bacterial proteins. * History of allergy or hypersensitivity to lidocaine or other amidetype anesthetics, or topical anesthetics or nerve blocking agents (if such products are intended to be used for that subject). Exclusion Criteria for Sub-study: • Subject was pregnant or nursing AND has no mammogram taken post GAL1906 treatment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Wrinkle are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Wrinkle

Contacts and locations

Locations

  • Galderma Research Site

    Birmingham, Alabama, 35209, United States

  • Galderma Research Site

    Scottsdale, Arizona, 85255, United States

  • Galderma Research Site

    Redondo Beach, California, 90277, United States

  • Galderma Research Site

    San Diego, California, 92121, United States

  • Galderma Research Site

    Vista, California, 92083, United States

  • Galderma Research Site

    Westport, Connecticut, 06880, United States

  • Galderma Research Site

    Boynton Beach, Florida, 33472, United States

  • Galderma Research Site

    Coral Gables, Florida, 33146, United States

  • Galderma Research Site

    Alpharetta, Georgia, 30022, United States

  • Galderma Research Site

    Chicago, Illinois, 60654, United States

  • Galderma Research Site

    Baltimore, Maryland, 21208, United States

  • Galderma Research Site

    New York, New York, 10021, United States

  • Galderma Research Site

    Spring, Texas, 77388, United States

  • Galderma Research Site

    Mequon, Wisconsin, 53092, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.